Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Surg Oncol. 2017 Jul 21;26(4):368–376. doi: 10.1016/j.suronc.2017.07.011

Table 1.

Clinical studies on specific bacteria and bacterial dysbiosis in esophageal cancer

Specific bacteria or bacterial dysbiosis Findings (References)
Esophageal squamous dysplasia and squamous cell carcinoma
Bacterial dysbiosis
  • Lower microbial diversity in the esophagus was associated with the presence of esophageal squamous dysplasia (85).

  • Lower microbial diversity in oral microbiota was associated with the presence of esophageal squamous cell carcinoma (86).

  • The composition of the gastric mucosal microbiota differs in early stage esophageal squamous cell carcinoma and esophageal squamous dysplasia from the healthy esophagus (87).

Fusobacterium nucleatum
  • A high amount of Fusobacterium nucleatum was associated with shorter cancer-specific survival and overall survival in esophageal cancer, and the amount of Fusobacterium nucleatum correlated with tumor expression of the chemokine CCL20 (93).

Barrett’s esophagus and esophageal adenocarcinoma
Helicobacter pylori
  • Infection with CagA-positve strains of Helicobacter pylori was associated with decreased risk of esophageal adenocarcinoma (88, 89).

  • Infection with Helicobacter pylori in the stomach was associated with decreased genomic instability in Barrett’s esophagus (90).

Escherichia coli
  • A high amount of Escherichia coli was associated with Barrett’s esophagus and esophageal adenocarcinoma and the activation of the Toll-like receptor signaling pathway (91).

Campylobacter concisus
  • A high amount of Campylobacter concisus was associated with increased expression of IL18 that was associated with carcinogenesis in Barrett’s esophagus (92).